Gregory Bunt, President of the International Society of Addiction Medicine

Dr. Gregory Bunt graduated medical school in 1983 from NYU School of Medicine, and completed his residency in Psychiatry at the Albert Einstein College of Medicine in 1987.  He was among the first to complete the Fellowship in Addiction Psychiatry at NYU School of Medicine (1989), and has since been on the NYU Medical School …Read more »

Nora D. Volkow, Director of the NIDA

40 ára afmælisráðstefna SÁÁ Nora D. Volkow, M.D., became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. Dr. Volkow’s work has been instrumental in demonstrating that drug addiction is a disease of the human brain.  As a research psychiatrist and scientist, Dr. Volkow pioneered the …Read more »

Paul Erley, Medical Director of the Georgia Professionals Health Program

Dr. Earley has been an Addiction Medicine Physician for over 30 years. He treats all types of addictive disorders and specializes in the assessment, treatment and management of health care professionals. As a therapist, he works with patients already in recovery, providing long term therapy for those who suffer from this disease. He is the …Read more »

Jeffrey Goldsmith, Past President of the American Society of Addiction Medicine

Dr. Goldsmith was in private practice from 1981-1994.  In 1994 Dr. Goldsmith joined the VA hospital fulltime and he currently works in the Buprenorphine Treatment Clinic and Dual Diagnosis Clinic in Cincinnati VAMC. From 1994-2009, Dr. Goldsmith worked in Dual Diagnosis Services and research with the Clinical Trials Network. He was an active member of …Read more »

Valgerður Rúnarsdóttir, Medical Director at SÁÁ

Valgerður Rúnarsdóttir MD, Medical Director of SÁÁ, graduated from medical school, University of Iceland 1992, internship in Iceland til 1995. Residency in Internal Medicine at Brown University program Rhode Island and to follow Addiction Medicine fellowship, 1995-2000. Board certified in Internal Medicine 1999 and Addiction Medicine 2000 in the US and licensed specialist in both …Read more »

Sigurður Ólafsson, Director of Hepatology, Landspitali University Hospital

Sigurdur Olafsson is Associate Professor of Medicine at the University of Iceland Faculty of Medicine and Director of Hepatology in the Division of Gastroenterology, Landspitali – The National University Hospital of Iceland. Dr. Olafsson received his Medical Degree from the University of Iceland in 1985 and undertook early postgraduate training at the University Hospital in …Read more »

Stephen Strobbe, Clinical Associate Professor

Dr. Stephen Strobbe is Clinical Associate Professor at the University of Michigan School of Nursing, and the Department of Psychiatry. He is board-certified both in psychiatric and addictions nursing. His professional background has included clinical care, research, administration, and education. He was the first Clinical Director for the University of Michigan Addiction Treatment Services (UMATS). …Read more »

Patrick G. O’Connor, M.D., M.P.H., F.A.C.P.

40 ára afmælisráðstefna SÁÁ Patrick G. O’Connor, MD, MPH, Professor of General Medicine, Chief, General Internal Medicine, Yale School of Medicine Dr. Patrick O’Connor is a Dan Adams and Amanda Adams Professor of General Medicine and Chief of General Internal Medicine at Yale University School of Medicine and Yale-New Haven Hospital in New Haven, Connecticut. …Read more »

Kári Stefánsson, CEO Decode Genetics

Kári Stefánsson, M.D., Dr. Med. has served as President, Chief Executive Officer and a Director since he founded deCODE genetics in August 1996. Dr. Stefánsson was appointed the Chairman of the Board of Directors of deCODE genetics in December 1999. From 1993 until April 1997, Dr. Stefánsson was a professor of Neurology, Neuropathology and Neuroscience …Read more »